The Organoids and Spheroids Market was valued at USD 1.86 Billion in 2024, and is projected to reach USD 6.27 Billion by 2030, rising at a CAGR of 23.23%. A rise in the adoption of organoid cultures in drug discovery, and rising demand for cell therapy and tissue engineering across the globe is expected to drive the market.
3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.
A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.
This product will be delivered within 2 business days.
3D spheroids are considered as an important aspect of tissue engineering and regenerative medicine research as they can be used as building blocks for the generation of complex tissues and organs. In addition, the potential of 3D cell cultures to be used as models for drug screening and analysis of human disorders are expected to provide ample growth opportunities to the market in the near future.
A rise in the adoption of organoid cultures for the assessment of the mechanism of human-specific disorders is expected to enhance the market growth. For instance, human organoids have helped in the analysis of a wide range of tissues including the small intestine, prostate, brain, and liver. The promise of the generation of 3D cell cultures that resemble human organs has brought an enormous potential for the use of organoids as cell therapies, and as prospective substitutes for whole-organ transplantation.
Organoids and Spheroids Market Report Highlights
- Based on type, the organoids segment led the market with the largest revenue share of 59.65% in 2024. The organoid market is primarily driven by the increasing demand for physiologically relevant 3D cell culture models in drug discovery, disease modeling, and personalized medicine.
- Based on application, the developmental biology segment led the market with the largest revenue share of 30.17% in 2024, owing to the rising usage of organoid and spheroid culture systems for developmental biology.
- Based on end use, the biotechnology and pharmaceutical industries segment led the market with the largest revenue share of 46.32% in 2024.
- North America dominated the organoids and spheroids market with the largest revenue share of 34.72% in 2024.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Organoids & Spheroids Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High adoption of organoids & spheroids in drug discovery
3.2.1.2. Technological advancements
3.2.1.3. Rising demand for tissue engineering & organ transplantation
3.2.2. Market restraint analysis
3.2.2.1. Challenges associated with 3D cell culturing
3.2.2.2. Ethical issues associated with organoid & spheroid cultures
3.3. Organoids & Spheroids Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High adoption of organoids & spheroids in drug discovery
3.2.1.2. Technological advancements
3.2.1.3. Rising demand for tissue engineering & organ transplantation
3.2.2. Market restraint analysis
3.2.2.1. Challenges associated with 3D cell culturing
3.2.2.2. Ethical issues associated with organoid & spheroid cultures
3.3. Organoids & Spheroids Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Segment Dashboard
4.2. Global Organoids & Spheroids Market: Type Movement Analysis
4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Organoids
4.4.1. Organoids market estimates and forecast, 2018-2030
4.4.2. Organoids by Type
4.4.2.1. Neural Organoids
4.4.2.1.1. Neural organoids market estimates and forecast, 2018-2030
4.4.2.2. Hepatic Organoids
4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018-2030
4.4.2.3. Intestinal organoids
4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018-2030
4.4.2.4. Other organoids
4.4.2.4.1. Other organoids market estimates and forecast, 2018-2030
4.4.3. Organoids by Method
4.4.3.1. General Submerged Method for Organoid Culture
4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018-2030
4.4.3.2. Crypt Organoid Culture Techniques
4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018-2030
4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018-2030
4.4.3.4. Clonal Organoids from Lgr5+ Cells
4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018-2030
4.4.3.5. Brain and Retina Organoid Formation Protocol
4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018-2030
4.4.3.6. Others
4.4.3.6.1. Others market estimates and forecast, 2018-2030
4.4.4. Organoids by Source
4.4.4.1. Primary Tissues
4.4.4.1.1. Primary tissues market estimates and forecast, 2018-2030
4.4.4.2. Stem Cells
4.4.4.2.1. Stem cells market estimates and forecast, 2018-2030
4.5. Spheroids
4.5.1. Spheroids market estimates and forecast, 2018-2030
4.5.2. Spheroids by Type
4.5.2.1. Multicellular tumor spheroids (MCTS)
4.5.2.1.1. MCTS market estimates and forecast, 2018-2030
4.5.2.2. Neurospheres
4.5.2.2.1. Neurospheres market estimates and forecast, 2018-2030
4.5.2.3. Mammospheres
4.5.2.3.1. Mammospheres market estimates and forecast, 2018-2030
4.5.2.4. Hepatospheres
4.5.2.4.1. Hepatospheres market estimates and forecast, 2018-2030
4.5.2.5. Embryoid bodies
4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018-2030
4.5.3. Spheroids by Method
4.5.3.1. Micropatterned Plates
4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018-2030
4.5.3.2. Low Cell Attachment Plates
4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018-2030
4.5.3.3. Hanging Drop Method
4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018-2030
4.5.3.4. Others
4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018-2030
4.5.4. Spheroids by Source
4.5.4.1. Cell Line
4.5.4.1.1. Cell line market estimates and forecast, 2018-2030
4.5.4.2. Primary Cell
4.5.4.2.1. Primary cell market estimates and forecast, 2018-2030
4.5.4.3. iPSCs Derived Cells
4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018-2030
4.2. Global Organoids & Spheroids Market: Type Movement Analysis
4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Organoids
4.4.1. Organoids market estimates and forecast, 2018-2030
4.4.2. Organoids by Type
4.4.2.1. Neural Organoids
4.4.2.1.1. Neural organoids market estimates and forecast, 2018-2030
4.4.2.2. Hepatic Organoids
4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018-2030
4.4.2.3. Intestinal organoids
4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018-2030
4.4.2.4. Other organoids
4.4.2.4.1. Other organoids market estimates and forecast, 2018-2030
4.4.3. Organoids by Method
4.4.3.1. General Submerged Method for Organoid Culture
4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018-2030
4.4.3.2. Crypt Organoid Culture Techniques
4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018-2030
4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018-2030
4.4.3.4. Clonal Organoids from Lgr5+ Cells
4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018-2030
4.4.3.5. Brain and Retina Organoid Formation Protocol
4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018-2030
4.4.3.6. Others
4.4.3.6.1. Others market estimates and forecast, 2018-2030
4.4.4. Organoids by Source
4.4.4.1. Primary Tissues
4.4.4.1.1. Primary tissues market estimates and forecast, 2018-2030
4.4.4.2. Stem Cells
4.4.4.2.1. Stem cells market estimates and forecast, 2018-2030
4.5. Spheroids
4.5.1. Spheroids market estimates and forecast, 2018-2030
4.5.2. Spheroids by Type
4.5.2.1. Multicellular tumor spheroids (MCTS)
4.5.2.1.1. MCTS market estimates and forecast, 2018-2030
4.5.2.2. Neurospheres
4.5.2.2.1. Neurospheres market estimates and forecast, 2018-2030
4.5.2.3. Mammospheres
4.5.2.3.1. Mammospheres market estimates and forecast, 2018-2030
4.5.2.4. Hepatospheres
4.5.2.4.1. Hepatospheres market estimates and forecast, 2018-2030
4.5.2.5. Embryoid bodies
4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018-2030
4.5.3. Spheroids by Method
4.5.3.1. Micropatterned Plates
4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018-2030
4.5.3.2. Low Cell Attachment Plates
4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018-2030
4.5.3.3. Hanging Drop Method
4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018-2030
4.5.3.4. Others
4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018-2030
4.5.4. Spheroids by Source
4.5.4.1. Cell Line
4.5.4.1.1. Cell line market estimates and forecast, 2018-2030
4.5.4.2. Primary Cell
4.5.4.2.1. Primary cell market estimates and forecast, 2018-2030
4.5.4.3. iPSCs Derived Cells
4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018-2030
Chapter 5. End Use Business Analysis
5.1. Segment Dashboard
5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Biotechnology and Pharmaceutical Industries
5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
5.5. Academic & Research Institutes
5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
5.6. Hospitals and Diagnostic Centers
5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)
5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Biotechnology and Pharmaceutical Industries
5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
5.5. Academic & Research Institutes
5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
5.6. Hospitals and Diagnostic Centers
5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)
Chapter 6. Application Business Analysis
6.1. Segment Dashboard
6.2. Global Organoids & Spheroids Market: Application Movement Analysis
6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Developmental Biology
6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
6.5. Personalized Medicine
6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
6.6. Regenerative Medicine
6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
6.7. Disease Pathology Studies
6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
6.8. Drug Toxicity & Efficacy Testing
6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)
6.2. Global Organoids & Spheroids Market: Application Movement Analysis
6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Developmental Biology
6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
6.5. Personalized Medicine
6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
6.6. Regenerative Medicine
6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
6.7. Disease Pathology Studies
6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
6.8. Drug Toxicity & Efficacy Testing
6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Regional Business Analysis, by Country, Type, Application, & End Use
7.1. Segment Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. U.S. market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Canada market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Mexico market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4. Europe
7.4.1. Europe Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. UK market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Germany market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. France market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Italy market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Spain market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Denmark market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Sweden market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Norway market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5. Asia Pacific
7.5.1. Asia Pacific Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.2. China
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. China market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.3. Japan
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Japan market estimates and forecast, 2018-2030 (Volume, Thousand)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. India market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Australia market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Thailand market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. South Korea market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.6. Latin America
7.6.1. Latin America Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Brazil market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Argentina market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7. MEA
7.7.1. MEA Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.3. South Africa
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. South Africa market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. UAE market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Kuwait market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. U.S. market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Canada market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Mexico market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4. Europe
7.4.1. Europe Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. UK market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Germany market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. France market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Italy market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Spain market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Denmark market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Sweden market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Norway market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5. Asia Pacific
7.5.1. Asia Pacific Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.2. China
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. China market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.3. Japan
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Japan market estimates and forecast, 2018-2030 (Volume, Thousand)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. India market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Australia market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Thailand market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. South Korea market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.6. Latin America
7.6.1. Latin America Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Brazil market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Argentina market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7. MEA
7.7.1. MEA Market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.3. South Africa
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. South Africa market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. UAE market estimates and forecast, 2018-2030 (Revenue, USD Billion)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Kuwait market estimates and forecast, 2018-2030 (Revenue, USD Billion)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Lonza
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. 3D Biomatrix
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3D Biotek LLC
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. AMS Biotechnology (Europe) Limited
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cellesce Ltd
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Corning Incorporated
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Greiner Bio-One
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hubrecht Organoid Technology (HUB)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. InSphero
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Prellis Biologics
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. STEMCELL Technologies Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
8.2. Strategy Mapping
8.3. Company Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Lonza
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. 3D Biomatrix
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3D Biotek LLC
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. AMS Biotechnology (Europe) Limited
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cellesce Ltd
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Corning Incorporated
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Greiner Bio-One
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hubrecht Organoid Technology (HUB)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. InSphero
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Prellis Biologics
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. STEMCELL Technologies Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 3 North America organoids and spheroids market, by End Use, 2018-2030 (USD Million)
Table 4 North America organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 5 North America organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 6 U.S. organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 7 U.S. organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 8 U.S. organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 9 Canada organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 10 Canada organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 11 Canada organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 12 Mexico organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 13 Mexico organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 14 Mexico organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 15 Europe organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 16 Europe organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 17 Europe organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 18 Europe organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 19 Germany organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 20 Germany organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 21 Germany organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 22 UK organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 23 UK organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 24 UK organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 25 France organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 26 France organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 27 France organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 28 Italy organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 29 Italy organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 30 Italy organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 31 Spain organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 32 Spain organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 33 Spain organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 34 Sweden organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 35 Sweden organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 36 Sweden organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 37 Norway organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 38 Norway organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 39 Norway organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 40 Denmark organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 41 Denmark organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 42 Denmark organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 43 APAC organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 44 APAC organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 45 APAC organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 46 APAC organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 47 China organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 48 China organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 49 China organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 50 Japan organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 51 Japan organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 52 Japan organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 53 India organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 54 India organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 55 India organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 56 Thailand organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 57 Thailand organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 58 Thailand organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 59 South Korea organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 60 South Korea organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 61 South Korea organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 62 Australia organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 63 Australia organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 64 Australia organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 65 Latin America organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 66 Latin America organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 67 Latin America organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 68 Latin America organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 69 Brazil organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 70 Brazil organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 71 Brazil organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 72 Argentina organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 73 Argentina organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 74 Argentina organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 75 Middle East and Africa organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 76 Middle East and Africa organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 77 Middle East and Africa organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 78 Middle East and Africa organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 79 South Africa organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 80 South Africa organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 81 South Africa organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 82 Saudi Arabia organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 83 Saudi Arabia organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 84 Saudi Arabia organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 85 UAE organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 86 UAE organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 87 UAE organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 88 Kuwait organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 89 Kuwait organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 90 Kuwait organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 2 North America organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 3 North America organoids and spheroids market, by End Use, 2018-2030 (USD Million)
Table 4 North America organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 5 North America organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 6 U.S. organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 7 U.S. organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 8 U.S. organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 9 Canada organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 10 Canada organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 11 Canada organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 12 Mexico organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 13 Mexico organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 14 Mexico organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 15 Europe organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 16 Europe organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 17 Europe organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 18 Europe organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 19 Germany organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 20 Germany organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 21 Germany organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 22 UK organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 23 UK organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 24 UK organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 25 France organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 26 France organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 27 France organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 28 Italy organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 29 Italy organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 30 Italy organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 31 Spain organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 32 Spain organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 33 Spain organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 34 Sweden organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 35 Sweden organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 36 Sweden organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 37 Norway organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 38 Norway organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 39 Norway organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 40 Denmark organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 41 Denmark organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 42 Denmark organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 43 APAC organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 44 APAC organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 45 APAC organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 46 APAC organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 47 China organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 48 China organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 49 China organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 50 Japan organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 51 Japan organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 52 Japan organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 53 India organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 54 India organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 55 India organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 56 Thailand organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 57 Thailand organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 58 Thailand organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 59 South Korea organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 60 South Korea organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 61 South Korea organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 62 Australia organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 63 Australia organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 64 Australia organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 65 Latin America organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 66 Latin America organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 67 Latin America organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 68 Latin America organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 69 Brazil organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 70 Brazil organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 71 Brazil organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 72 Argentina organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 73 Argentina organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 74 Argentina organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 75 Middle East and Africa organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 76 Middle East and Africa organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 77 Middle East and Africa organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 78 Middle East and Africa organoids and spheroids market, by region, 2018-2030 (USD Million)
Table 79 South Africa organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 80 South Africa organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 81 South Africa organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 82 Saudi Arabia organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 83 Saudi Arabia organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 84 Saudi Arabia organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 85 UAE organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 86 UAE organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 87 UAE organoids and spheroids market, by application, 2018-2030 (USD Million)
Table 88 Kuwait organoids and spheroids market, by type, 2018-2030 (USD Million)
Table 89 Kuwait organoids and spheroids market, by end use, 2018-2030 (USD Million)
Table 90 Kuwait organoids and spheroids market, by application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Organoids and Spheroids: Market Outlook
Figure 9 Organoids and Spheroids competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Organoids and Spheroids market driver impact
Figure 13 Organoids and Spheroids market restraint impact
Figure 14 Organoids and Spheroids market strategic initiatives analysis
Figure 15 Organoids and Spheroids market: type movement analysis
Figure 16 Organoids and Spheroids market: type outlook and key takeaways
Figure 17 Neural organoids market estimates and forecast, 2018-2030
Figure 18 Hepatic organoids market estimates and forecast, 2018-2030
Figure 19 Intestinal organoids market estimates and forecast, 2018-2030
Figure 20 Other organoids market estimates and forecast, 2018-2030
Figure 21 General submerged method for organoid culture market estimates and forecast, 2018-2030
Figure 22 Crypt organoid culture techniques market estimates and forecast, 2018-2030
Figure 23 ALI method for organoid culture market estimates and forecast, 2018-2030
Figure 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018-2030
Figure 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018-2030
Figure 26 Others Organoid Formation Protocol market estimates and forecast, 2018-2030
Figure 27 Primary tissues market estimates and forecast, 2018-2030
Figure 28 Stem cells market estimates and forecast, 2018-2030
Figure 29 Spheroids market estimates and forecast, 2018-2030
Figure 30 MCTS market estimates and forecast, 2018-2030
Figure 31 Neurospheres market estimates and forecast, 2018-2030
Figure 32 Mammospheres market estimates and forecast, 2018-2030
Figure 33 Hepatospheres market estimates and forecast, 2018-2030
Figure 34 Embryoid bodies market estimates and forecast, 2018-2030
Figure 35 Micropatterned plates market estimates and forecast, 2018-2030
Figure 36 Low cell attachment plates market estimates and forecast, 2018-2030
Figure 37 Hanging drop method for spheroid culture market estimates and forecast, 2018-2030
Figure 38 Other methods for spheroid culture market estimates and forecast, 2018-2030
Figure 39 Cell line market estimates and forecast, 2018-2030
Figure 40 Primary cell market estimates and forecast, 2018-2030
Figure 41 iPSCs derived cells market estimates and forecast, 2018-2030
Figure 42 Organoids and spheroids market: End Use movement analysis
Figure 43 Organoids and spheroids market: End Use outlook and key takeaways
Figure 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018-2030
Figure 45 Academic & research institutes market estimates and forecast, 2018-2030
Figure 46 Hospitals and diagnostic centers market estimates and forecast, 2018-2030
Figure 47 Organoids and spheroids market: application movement analysis
Figure 48 Organoids and spheroids market: application outlook and key takeaways
Figure 49 Developmental biology market estimates and forecast, 2018-2030
Figure 50 Personalized medicine market estimates and forecast, 2018-2030
Figure 51 Regenerative medicine market estimates and forecast, 2018-2030
Figure 52 Disease pathology studies market estimates and forecast, 2018-2030
Figure 53 Drug toxicity & efficacy testing market estimates and forecast, 2018-2030
Figure 54 Global Organoids and spheroids market: regional movement analysis
Figure 55 Global Organoids and spheroids market: regional outlook and key takeaways
Figure 56 North America
Figure 57 North America market estimates and forecast, 2018-2030
Figure 58 US key country dynamics
Figure 59 US market estimates and forecast, 2018-2030
Figure 60 Canada key country dynamics
Figure 61 Canada market estimates and forecast, 2018-2030
Figure 62 Mexico key country dynamics
Figure 63 Mexico market estimates and forecast, 2018-2030
Figure 64 Europe
Figure 65 Europe market estimates and forecast, 2018-2030
Figure 66 UK key country dynamics
Figure 67 UK market estimates and forecast, 2018-2030
Figure 68 Germany key country dynamics
Figure 69 Germany market estimates and forecast, 2018-2030
Figure 70 France key country dynamics
Figure 71 France market estimates and forecast, 2018-2030
Figure 72 Italy key country dynamics
Figure 73 Italy market estimates and forecast, 2018-2030
Figure 74 Spain key country dynamics
Figure 75 Spain market estimates and forecast, 2018-2030
Figure 76 Sweden key country dynamics
Figure 77 Sweden market estimates and forecast, 2018-2030
Figure 78 Norway key country dynamics
Figure 79 Norway market estimates and forecast, 2018-2030
Figure 80 Denmark key country dynamics
Figure 81 Denmark market estimates and forecast, 2018-2030
Figure 82 Asia Pacific
Figure 83 Asia Pacific market estimates and forecast, 2018-2030
Figure 84 China key country dynamics
Figure 85 China market estimates and forecast, 2018-2030
Figure 86 Japan key country dynamics
Figure 87 Japan market estimates and forecast, 2018-2030
Figure 88 India key country dynamics
Figure 89 India market estimates and forecast, 2018-2030
Figure 90 Australia key country dynamics
Figure 91 Australia market estimates and forecast, 2018-2030
Figure 92 Thailand key country dynamics
Figure 93 Thailand market estimates and forecast, 2018-2030
Figure 94 South Korea key country dynamics
Figure 95 South Korea market estimates and forecast, 2018-2030
Figure 96 Latin America
Figure 97 Latin America market estimates and forecast, 2018-2030
Figure 98 Brazil key country dynamics
Figure 99 Brazil market estimates and forecast, 2018-2030
Figure 100 Argentina key country dynamics
Figure 101 Argentina market estimates and forecast, 2018-2030
Figure 102 Middle East and Africa
Figure 103 Middle East and Africa market estimates and forecast, 2018-2030
Figure 104 Saudi Arabia key country dynamics
Figure 105 Saudi Arabia market estimates and forecast, 2018-2030
Figure 106 South Africa key country dynamics
Figure 107 South Africa market estimates and forecast, 2018-2030
Figure 108 UAE key country dynamics
Figure 109 UAE market estimates and forecast, 2018-2030
Figure 110 Kuwait key country dynamics
Figure 111 Kuwait market estimates and forecast, 2018-2030
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Organoids and Spheroids: Market Outlook
Figure 9 Organoids and Spheroids competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Organoids and Spheroids market driver impact
Figure 13 Organoids and Spheroids market restraint impact
Figure 14 Organoids and Spheroids market strategic initiatives analysis
Figure 15 Organoids and Spheroids market: type movement analysis
Figure 16 Organoids and Spheroids market: type outlook and key takeaways
Figure 17 Neural organoids market estimates and forecast, 2018-2030
Figure 18 Hepatic organoids market estimates and forecast, 2018-2030
Figure 19 Intestinal organoids market estimates and forecast, 2018-2030
Figure 20 Other organoids market estimates and forecast, 2018-2030
Figure 21 General submerged method for organoid culture market estimates and forecast, 2018-2030
Figure 22 Crypt organoid culture techniques market estimates and forecast, 2018-2030
Figure 23 ALI method for organoid culture market estimates and forecast, 2018-2030
Figure 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018-2030
Figure 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018-2030
Figure 26 Others Organoid Formation Protocol market estimates and forecast, 2018-2030
Figure 27 Primary tissues market estimates and forecast, 2018-2030
Figure 28 Stem cells market estimates and forecast, 2018-2030
Figure 29 Spheroids market estimates and forecast, 2018-2030
Figure 30 MCTS market estimates and forecast, 2018-2030
Figure 31 Neurospheres market estimates and forecast, 2018-2030
Figure 32 Mammospheres market estimates and forecast, 2018-2030
Figure 33 Hepatospheres market estimates and forecast, 2018-2030
Figure 34 Embryoid bodies market estimates and forecast, 2018-2030
Figure 35 Micropatterned plates market estimates and forecast, 2018-2030
Figure 36 Low cell attachment plates market estimates and forecast, 2018-2030
Figure 37 Hanging drop method for spheroid culture market estimates and forecast, 2018-2030
Figure 38 Other methods for spheroid culture market estimates and forecast, 2018-2030
Figure 39 Cell line market estimates and forecast, 2018-2030
Figure 40 Primary cell market estimates and forecast, 2018-2030
Figure 41 iPSCs derived cells market estimates and forecast, 2018-2030
Figure 42 Organoids and spheroids market: End Use movement analysis
Figure 43 Organoids and spheroids market: End Use outlook and key takeaways
Figure 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018-2030
Figure 45 Academic & research institutes market estimates and forecast, 2018-2030
Figure 46 Hospitals and diagnostic centers market estimates and forecast, 2018-2030
Figure 47 Organoids and spheroids market: application movement analysis
Figure 48 Organoids and spheroids market: application outlook and key takeaways
Figure 49 Developmental biology market estimates and forecast, 2018-2030
Figure 50 Personalized medicine market estimates and forecast, 2018-2030
Figure 51 Regenerative medicine market estimates and forecast, 2018-2030
Figure 52 Disease pathology studies market estimates and forecast, 2018-2030
Figure 53 Drug toxicity & efficacy testing market estimates and forecast, 2018-2030
Figure 54 Global Organoids and spheroids market: regional movement analysis
Figure 55 Global Organoids and spheroids market: regional outlook and key takeaways
Figure 56 North America
Figure 57 North America market estimates and forecast, 2018-2030
Figure 58 US key country dynamics
Figure 59 US market estimates and forecast, 2018-2030
Figure 60 Canada key country dynamics
Figure 61 Canada market estimates and forecast, 2018-2030
Figure 62 Mexico key country dynamics
Figure 63 Mexico market estimates and forecast, 2018-2030
Figure 64 Europe
Figure 65 Europe market estimates and forecast, 2018-2030
Figure 66 UK key country dynamics
Figure 67 UK market estimates and forecast, 2018-2030
Figure 68 Germany key country dynamics
Figure 69 Germany market estimates and forecast, 2018-2030
Figure 70 France key country dynamics
Figure 71 France market estimates and forecast, 2018-2030
Figure 72 Italy key country dynamics
Figure 73 Italy market estimates and forecast, 2018-2030
Figure 74 Spain key country dynamics
Figure 75 Spain market estimates and forecast, 2018-2030
Figure 76 Sweden key country dynamics
Figure 77 Sweden market estimates and forecast, 2018-2030
Figure 78 Norway key country dynamics
Figure 79 Norway market estimates and forecast, 2018-2030
Figure 80 Denmark key country dynamics
Figure 81 Denmark market estimates and forecast, 2018-2030
Figure 82 Asia Pacific
Figure 83 Asia Pacific market estimates and forecast, 2018-2030
Figure 84 China key country dynamics
Figure 85 China market estimates and forecast, 2018-2030
Figure 86 Japan key country dynamics
Figure 87 Japan market estimates and forecast, 2018-2030
Figure 88 India key country dynamics
Figure 89 India market estimates and forecast, 2018-2030
Figure 90 Australia key country dynamics
Figure 91 Australia market estimates and forecast, 2018-2030
Figure 92 Thailand key country dynamics
Figure 93 Thailand market estimates and forecast, 2018-2030
Figure 94 South Korea key country dynamics
Figure 95 South Korea market estimates and forecast, 2018-2030
Figure 96 Latin America
Figure 97 Latin America market estimates and forecast, 2018-2030
Figure 98 Brazil key country dynamics
Figure 99 Brazil market estimates and forecast, 2018-2030
Figure 100 Argentina key country dynamics
Figure 101 Argentina market estimates and forecast, 2018-2030
Figure 102 Middle East and Africa
Figure 103 Middle East and Africa market estimates and forecast, 2018-2030
Figure 104 Saudi Arabia key country dynamics
Figure 105 Saudi Arabia market estimates and forecast, 2018-2030
Figure 106 South Africa key country dynamics
Figure 107 South Africa market estimates and forecast, 2018-2030
Figure 108 UAE key country dynamics
Figure 109 UAE market estimates and forecast, 2018-2030
Figure 110 Kuwait key country dynamics
Figure 111 Kuwait market estimates and forecast, 2018-2030
Companies Mentioned
The companies profiled in this Organoids and Spheroids market report include:- 3D Biomatrix
- 3D Biotek LLC
- AMS Biotechnology (Europe) Limited
- Cellesce Ltd.
- Corning Incorporated
- Greiner Bio-One
- Hubrecht Organoid Technology (HUB)
- InSphero
- Lonza
- Merck KGaA
- Prellis Biologics
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific, Inc.
Methodology
LOADING...
